These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28529878)

  • 21. Assessment of the progression of Parkinson's disease: a metabolic network approach.
    Eckert T; Tang C; Eidelberg D
    Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism.
    Beauchamp LC; Villemagne VL; Finkelstein DI; Doré V; Bush AI; Barnham KJ; Rowe CC
    Sci Rep; 2020 Oct; 10(1):17631. PubMed ID: 33097764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
    Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
    Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder.
    Ansari M; Rahmani F; Dolatshahi M; Pooyan A; Aarabi MH
    Sleep Breath; 2017 Mar; 21(1):155-161. PubMed ID: 27853964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodromal PD: A new nosological entity.
    Schaeffer E; Postuma RB; Berg D
    Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
    Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
    Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.
    Ryman SG; Poston KL
    Parkinsonism Relat Disord; 2020 Apr; 73():85-93. PubMed ID: 31629653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis.
    Conrado DJ; Nicholas T; Tsai K; Macha S; Sinha V; Stone J; Corrigan B; Bani M; Muglia P; Watson IA; Kern VD; Sheveleva E; Marek K; Stephenson DT; Romero K;
    Clin Transl Sci; 2018 Jan; 11(1):63-70. PubMed ID: 28749580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural MRI in Idiopathic Parkinson's Disease.
    De Micco R; Russo A; Tessitore A
    Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?
    Hanganu A; Monchi O
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):91. PubMed ID: 30324260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and neuroimaging markers of neurodegeneration in first-degree relatives of patients with REM sleep behavior disorder with and without isolated rapid eye movement sleep without atonia: A case-control clinical and dopamine PET study.
    Chau SWH; Liu Y; Zhang J; Leung E; Chen S; Ho CL; Chan JWY; Tsang CC; Li SX; Huang B; Lam SP; Mok VC; Wing YK
    Parkinsonism Relat Disord; 2023 Feb; 107():105271. PubMed ID: 36634468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional MRI in Idiopathic Parkinson's Disease.
    Filippi M; Elisabetta S; Piramide N; Agosta F
    Int Rev Neurobiol; 2018; 141():439-467. PubMed ID: 30314606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
    Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline.
    Barber TR; Griffanti L; Bradley KM; McGowan DR; Lo C; Mackay CE; Hu MT; Klein JC
    Ann Clin Transl Neurol; 2020 Jan; 7(1):26-35. PubMed ID: 31820587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.